MedTrace Logo

Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation

NCT03958344 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-02-16

No results posted yet for this study

Summary

A multicenter randomised double-arm clinical trial, to compare safety and efficacy of oral versus intralesional injection of steroid in a group of patients suffering from idiopathic orbital inflammation is designed. Outcome measures include number of recurrences, duration of remission, and side effects.

Conditions

  • Orbital Pseudotumor

Interventions

DRUG

Prednisolone

Oral Tablet

DRUG

Triamcinolone + Betamethason

A compound long acting and short acting injectable steroid

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    collaborator OTHER

  • Mashhad University of Medical Sciences

    collaborator OTHER

  • Shahid Beheshti University of Medical Sciences

    collaborator OTHER

  • Iran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mohsen B Kashkouli, MD · Iran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-06-01
Completion
2025-06-01

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03958344 on ClinicalTrials.gov